Loading...

Caitlin Costello

Title(s)Assistant Clinical Professor of Medicine, Medicine
SchoolHealth Sciences
Phone858-822-6600
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Harvard University2002Cum Laude
    2004Robert J. Fahey Award for Compassion in Doctoring
    2006Worth F Bloom Award for High Standard of Excellence and Level of Compassion
    2010  - 2012Akliviadis Vasiliadis Fellowship Award for Clinical Research
    2011American Society of Hematology Abstract Achievement Award
    2012American Society of Clinical Oncology Travel Award

    Collapse Overview 
    Collapse Overview
    Research Interests
    As a member of the Division of Blood and Marrow Transplantation, Dr Costello is dedicated to providing excellent care for patients with a variety of hematologic malignancies, with a specific focus in lymphoproliferative disorders and bone marrow transplantation. Dr Costello’s research interests focus particularly on the refinement of the management and treatment of multiple myeloma. She is dedicated to conducting clinical trials with novel agents and treatment strategies to expand the therapeutic options for patients with multiple myeloma. As we enter the age of personalized medicine, Dr. Costello is principally interested in developing treatment strategies that are specific to the most finite genetic and molecular details of each individual patient’s disease.

    Education and Training
    BA - Biology, Harvard University, Cambridge, MA - 2002
    MD - Medicine, Tufts University, School of Medicine, Boston, MA - 2006
    Internship/Residency - Internal Medicine, New York Presbyterial/Weill Cornell Medical Center, New York, NY - 2006-2009
    Fellowship - Hematology/Oncology, University of California, San Diego, CA - 2009-2012

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Costello C. The future of checkpoint inhibition in multiple myeloma? Lancet Haematol. 2019 09; 6(9):e439-e440. PMID: 31327688.
      View in: PubMed
    2. Richardson PG, Bensinger WI, Huff CA, Costello CL, Lendvai N, Berdeja JG, Anderson LD, Siegel DS, Lebovic D, Jagannath S, Laubach JP, Stockerl-Goldstein KE, Kwei L, Clow F, Elias L, Salman Z, Graef T, Bilotti E, Vij R. Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. Br J Haematol. 2018 03; 180(6):821-830. PMID: 29435979.
      View in: PubMed
    3. Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R. Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2015 Nov; 13(11):1398-435. PMID: 26553768.
      View in: PubMed
    Caitlin's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (16) concept(s)
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑